Search

Zai Lab Ltd ADR

Chiusa

SettoreSettore sanitario

25.19 -4.44

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

24.73

Massimo

26.33

Metriche Chiave

By Trading Economics

Entrata

191K

-51M

Vendite

6.7M

106M

EPS

-0.46

Margine di Profitto

-47.808

Dipendenti

1,784

EBITDA

-2.1M

-46M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+48.76% upside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

914M

3B

Apertura precedente

29.63

Chiusura precedente

25.19

Notizie sul Sentiment di mercato

By Acuity

38%

62%

74 / 339 Classifica in Healthcare

Zai Lab Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 set 2026, 23:56 UTC

News

EUR/GBP rises as Germany's business expectations for September exceed forecasts, reaching 90.4 and indicating notable strength in today's performance.

24 set 2026, 23:55 UTC

News

LPL Financial reported total client assets of $2.60 trillion for August 2026, with the stock trading modestly lower in after-market hours.

24 set 2026, 23:55 UTC

News
Social Media

MGM Resorts International shares are modestly lower in after-market trading as it considers a bid for People Incorporated amid uncertain negotiations.

24 set 2026, 23:50 UTC

News

Regenxbio Inc. shares rose in after-market trading following positive three-year data for suragene lomparvovec, showing significant improvement in diabetic retinopathy patients.

24 set 2026, 23:46 UTC

News

Pentair PLC shares are trading lower in after-market hours amid a securities class action lawsuit alleging false statements about inventory issues affecting sales.

24 set 2026, 23:45 UTC

News

Global Payments Inc. is trading roughly flat in after-market hours, positioned below its 20-day moving average amid the Fed's announcement on cross-border transaction support.

24 set 2026, 23:45 UTC

News

EUR/NOK is trading higher as Germany's business expectations for September exceeded forecasts at 90.4, compared to the previous 89.

24 set 2026, 23:31 UTC

News

Celanese Corporation shares declined in after-market hours following the announcement of price increases for UHMW-PE and POM products, effective October 8, 2026.

24 set 2026, 23:30 UTC

Event
News

Merck & Co Inc's stock traded modestly lower in after-market hours following the announcement of Phase 2b/3 BRUNELLO trial results for diabetic macular edema.

24 set 2026, 23:21 UTC

News

CrowdStrike is collaborating with Snowflake to integrate its AI-native Falcon platform into the Snowflake Marketplace, with shares modestly higher in after-market trading.

24 set 2026, 23:16 UTC

Correlated Moves
News

Rockwell Automation shares traded lower in after-market hours following the announcement of Chief Revenue Officer Scott A. Genereux's retirement and Wells Fargo's Equal Weight rating.

24 set 2026, 23:16 UTC

News

EUR/JPY traded higher as Germany's September business expectations exceeded forecasts at 90.4, up from 89.3, contributing to modest gains in the currency pair.

24 set 2026, 23:06 UTC

News

General Electric Co has secured a $199.7 million contract for the R-391 Propeller Assembly, with shares modestly higher in after-market trading.

24 set 2026, 23:06 UTC

News

Wells Fargo analyst Joseph O'Dea initiated coverage on Otis Worldwide Corp with an Underweight rating, as shares traded roughly flat after market hours.

24 set 2026, 23:06 UTC

Social Media
News

GameStop's shares are trading lower in after-market hours despite CEO Ryan Cohen's reported share purchases, influenced by a broader market decline.

24 set 2026, 23:06 UTC

News
Event

Jabil Inc. shares are higher in after-market trading following a $1.7 billion contract manufacturing agreement with Akamai Technologies.

24 set 2026, 23:06 UTC

News

Delta Air Lines declared a quarterly dividend of $0.2150 per share, while its shares are declining in after-market trading amid broader market trends.

24 set 2026, 23:06 UTC

Social Media
News

Raises quarterly dividend to $1.17 per share

24 set 2026, 23:06 UTC

News

EUR/NZD is trading slightly higher as Germany's business expectations for September exceeded forecasts, coming in at 90.4, above the previous reading of 89.

24 set 2026, 23:06 UTC

Macro Event
News

The USD/NOK exchange rate is modestly higher, supported by lower U.S. initial jobless claims, reflecting recent macroeconomic developments.

24 set 2026, 23:06 UTC

Correlated Moves
News

U.S. natural gas storage levels reached 53 billion cubic feet, surpassing forecasts, while USD/ZAR trades modestly higher amid correlated movements with USD/MXN.

24 set 2026, 23:06 UTC

News

Newmont Corporation shares were roughly flat in after-market trading ahead of its Q3 2026 results announcement on October 22, 2026.

24 set 2026, 23:05 UTC

News

Vertiv Holdings Co shares rose in after-market hours after Wells Fargo initiated coverage with an Overweight rating and a $340.00 price target.

24 set 2026, 23:05 UTC

News

Automatic Data Processing Inc. is moving lower in after-market trading following the nomination of David W. Kenny and Nancy McKinstry to its Board of Directors.

24 set 2026, 23:05 UTC

News

Northrop Grumman Corp is trading roughly flat in after-market hours as the U.S. Air Force seeks input for replacing outdated radar systems.

24 set 2026, 23:01 UTC

News

nVent Electric PLC traded modestly lower in after-market hours following Wells Fargo's Equal Weight rating and $182.00 price target initiation by analyst Stephen Tusa.

24 set 2026, 23:01 UTC

News

AeroVironment Inc is declining in after-market trading despite securing a $464.8 million U.S. Army contract for its Enduring High Energy Laser program.

24 set 2026, 23:01 UTC

Social Media
News
Event

Costco reported fourth-quarter fiscal 2026 net sales of $93.9 billion and net income of $3.0 billion, exceeding expectations, with a slight increase in after-market trading.

24 set 2026, 23:01 UTC

News
Event

Scholastic Corp reported a fiscal Q1 net loss of $71.2 million and revenues of $216.8 million, prompting a sharp decline in shares after-market hours.

24 set 2026, 23:01 UTC

News

Starbucks plans to close about 250 locations, incurring $300 million in charges, while shares are modestly higher in after-market trading.

Confronto tra pari

Modifica del prezzo

Zai Lab Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

48.76% in crescita

Previsioni per 12 mesi

Media 39.333 USD  48.76%

Alto 45 USD

Basso 36 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zai Lab Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

74 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.